Edition:
United Kingdom

Exelixis’ Collaborator Daiichi Sankyo Receives Regulatory Approval For Minnebro Tablets In Japan


Tuesday, 8 Jan 2019 

Jan 8 (Reuters) - Exelixis Inc ::EXELIXIS’ COLLABORATOR DAIICHI SANKYO RECEIVES REGULATORY APPROVAL FOR MINNEBRO™ (ESAXERENONE) TABLETS FOR THE TREATMENT OF HYPERTENSION IN JAPAN.EXELIXIS INC - APPROVAL ALLOWS FOR MARKETING OF MINNEBRO FOR THE INDICATION WITHIN JAPAN..